
Results
190
Companies which are potentially undervalued and in an acceptable financial position.
190 companies
Otsuka Holdings
Market Cap: JP¥5.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,200.00
7D
-3.6%
1Y
40.7%
Pharma Mar
Market Cap: €1.2b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€67.00
7D
-30.3%
1Y
-19.0%
High Tide
Market Cap: CA$283.9m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.23
7D
0.3%
1Y
4.2%
Verastem
Market Cap: US$360.3m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$4.10
7D
10.5%
1Y
-26.8%
Kissei Pharmaceutical
Market Cap: JP¥161.9b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,905.00
7D
2.8%
1Y
-6.6%
Cipher Pharmaceuticals
Market Cap: CA$414.2m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$16.31
7D
-3.1%
1Y
24.6%
Arcutis Biotherapeutics
Market Cap: US$3.0b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$24.38
7D
14.8%
1Y
81.5%
CorMedix
Market Cap: US$685.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.74
7D
4.5%
1Y
-40.0%
Regeneron Pharmaceuticals
Market Cap: US$62.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$612.14
7D
-3.7%
1Y
15.7%
Hypera
Market Cap: R$15.1b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.49
7D
2.4%
1Y
-22.7%
Sanofi
Market Cap: €91.9b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.59
7D
-1.7%
1Y
-11.8%
Yunnan Baiyao GroupLtd
Market Cap: CN¥90.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.60
7D
3.7%
1Y
-10.4%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩244,500.00
7D
-0.6%
1Y
-31.3%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥54.6b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥22.36
7D
1.5%
1Y
-13.4%
Alembic Pharmaceuticals
Market Cap: ₹146.1b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹743.35
7D
0.7%
1Y
-25.6%
Supernus Pharmaceuticals
Market Cap: US$2.6b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$44.41
7D
-0.8%
1Y
38.7%
Vetoquinol
Market Cap: €812.4m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€69.90
7D
0.6%
1Y
-1.5%
Elanco Animal Health
Market Cap: US$12.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.17
7D
2.3%
1Y
75.0%
Bayer
Market Cap: €35.6b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€36.19
7D
0.08%
1Y
31.7%
Dong-A Socio Holdings
Market Cap: ₩544.2b
Engages in the pharmaceutical business in South Korea.
A000640
₩82,100.00
7D
-3.8%
1Y
-29.3%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,775.50
7D
-3.1%
1Y
11.6%
Dong-E-E-Jiao
Market Cap: CN¥32.4b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥50.48
7D
1.8%
1Y
-6.3%
Prestige Consumer Healthcare
Market Cap: US$2.3b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$47.82
7D
1.4%
1Y
-43.1%
Bavarian Nordic
Market Cap: DKK 14.1b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 184.10
7D
0.8%
1Y
0.1%
Diaceutics
Market Cap: UK£120.7m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.43
7D
0.7%
1Y
13.5%
Ardelyx
Market Cap: US$1.4b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.69
7D
2.3%
1Y
58.1%
Collegium Pharmaceutical
Market Cap: US$1.1b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$34.64
7D
3.8%
1Y
18.7%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.24
7D
0.8%
1Y
-8.8%
Genscript Biotech
Market Cap: HK$28.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$13.02
7D
0.8%
1Y
-19.8%
Amoy Diagnostics
Market Cap: CN¥6.5b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥16.98
7D
-14.7%
1Y
-21.4%
Fennec Pharmaceuticals
Market Cap: US$312.6m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$9.00
7D
3.4%
1Y
13.5%
Journey Medical
Market Cap: US$174.6m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.34
7D
6.2%
1Y
-6.5%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
0%
1Y
64.3%
Dong-A ST
Market Cap: ₩355.2b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,950.00
7D
-3.7%
1Y
-17.5%
Tarsus Pharmaceuticals
Market Cap: US$2.7b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$61.95
7D
4.5%
1Y
51.5%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩120,100.00
7D
-0.8%
1Y
-24.1%